BFT also influences immune cells by activating the TLRs signaling pathway, which upregulates IL-6 and TNF-α, further leading to the activation of STAT3 and NF-κB, thereby inhibiting anti-tumor immunity and promoting tumorigenesis (68). The gene discussed is STAT3; the disease is neoplasm.